Literature DB >> 2879636

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

C Knabbe, M E Lippman, L M Wakefield, K C Flanders, A Kasid, R Derynck, R B Dickson.   

Abstract

The hormone-dependent human breast cancer cell line MCF-7 secretes transforming growth factor-beta (TGF-beta), which can be detected in the culture medium in a biologically active form. These polypeptides compete with human platelet-derived TGF-beta for binding to its receptor, are biologically active in TGF-beta-specific growth assays, and are recognized and inactivated by TGF-beta-specific antibodies. Secretion of active TGF-beta is induced 8 to 27-fold under treatment of MCF-7 cells with growth inhibitory concentrations of antiestrogens. Antiestrogen-induced TGF-beta from MCF-7 cells inhibits the growth of an estrogen receptor-negative human breast cancer cell line in coculture experiments; growth inhibition is reversed with anti-TGF-beta antibodies. We conclude that in MCF-7 cells, TGF-beta is a hormonally regulated growth inhibitor with possible autocrine and paracrine functions in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2879636     DOI: 10.1016/0092-8674(87)90193-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  182 in total

1.  Dynamics of protein 27 of avian leukosis virus and transforming growth factor beta2 in lymphoid leukosis susceptible and resistant broiler chicken breeding stock.

Authors:  E K Barbour; M Bouljihad; B Hamdar; W Sakr; A Eid; B Safieh-Garabedian
Journal:  Vet Res Commun       Date:  1999-05       Impact factor: 2.459

Review 2.  The potential influence of radiation-induced microenvironments in neoplastic progression.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 3.  Estrogen responsiveness and control of normal human breast proliferation.

Authors:  E Anderson; R B Clarke; A Howell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

4.  Estrogen mitogenic action. III. is phenol red a "red herring"?

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

Review 5.  Role of mesenchymal-epithelial interactions in mammary gland development.

Authors:  G R Cunha; Y K Hom
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

Review 6.  The role of TGF-beta in patterning and growth of the mammary ductal tree.

Authors:  C W Daniel; S Robinson; G B Silberstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

Review 7.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

8.  Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy.

Authors:  C A Kristensen; L M Hamberg; G J Hunter; S Roberge; D Kierstead; G L Wolf; R K Jain
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

9.  Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.

Authors:  S De Placido; C Gallo; A Marinelli; F Perrone; C Pagliarulo; G Petrella; G Delrio; M D'Istria; L Del Mastro; A R Bianco
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

Review 10.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.